欢迎来到《四川大学学报(医学版)》

肥胖和2型糖尿病共同靶点及中药成分干预机制研究

Shared Therapeutic Targets of Obesity and Type 2 Diabetes Mellitus and the Intervention Mechanisms of Chinese Herbal Components

  • 摘要:
    目的 基于生物信息学方法探讨肥胖和2型糖尿病(type 2 diabetes mellitus, T2DM)的共同潜在靶点及分子机制,并通过动物实验验证核心靶点的表达,同时分析中药活性成分的干预潜力。
    方法 通过GEO数据库获取肥胖人群数据集(GSE151839、GSE162653)筛选差异表达基因,与GeneCards数据库中的T2DM靶点取交集获得共同靶点。利用STRING数据库构建蛋白质-蛋白质相互作用(PPI)网络,通过基因本体(GO)和京都基因与基因组百科全书(KEGG)分析富集生物过程和信号通路。采用GEO数据库验证核心靶点在肥胖和T2DM患者脂肪组织中的表达。12只SPF级雄性健康的8周龄SD大鼠(体质量180~200 g)随机分为空白组和模型组(n=6),建立T2DM大鼠模型,检测脂肪组织中核心靶点mRNA和蛋白表达水平。通过分子对接和分子动力学模拟分析中药活性成分与核心靶点的结合能力。
    结果 筛选获得肥胖差异表达基因460个(GSE151839)和796个(GSE162653),与T2DM靶点交集得到109个共同靶点。PPI网络分析鉴定出PTPRC、MMP9、ITGB2、CD86、CCR5和CCR2等核心靶点。GO和KEGG分析显示这些靶点主要富集于炎症反应、免疫调节和细胞黏附等生物学过程。动物实验验证核心靶点PTPRCITGAXMMP9ITGB2CCR2CXCL1 mRNA和蛋白在T2DM大鼠脂肪组织中表达上调(P<0.05)。分子对接和分子动力学模拟结果表明小檗碱、葛根素与PTPRC、MMP9、ITGB2靶点具有良好结合能力。
    结论 本研究揭示了肥胖与T2DM的共同分子机制,发现PTPRC、MMP9等核心靶点可能通过调控炎症-免疫网络促进疾病进展,为开发基于中药活性成分的靶向治疗策略提供了理论依据。

     

    Abstract:
    Objective To explore the shared potential targets and molecular mechanisms of obesity and type 2 diabetes mellitus (T2DM) using bioinformatics methods, to validate the expression of core targets through animal experiments, and to analyze the intervention potential of active components of traditional Chinese medicine (TCM).
    Methods The obese population datasets (GSE151839 and GSE162653) were obtained from the Gene Expression Omnibus (GEO) database to screen for differentially expressed genes, which were then intersected with T2DM-related targets from the GeneCards database to identify shared targets. A protein–protein interaction (PPI) network was constructed using the STRING database. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses were performed to identify enriched biological processes and signaling pathways. The expression of core targets in adipose tissue from patients with obesity and T2DM was validated using the GEO database. A total of 12 specific-pathogen-free (SPF) male Sprague-Dawley (SD) rats, aged 8 weeks and weighing between 180 and 200 g, were randomly assigned to a control group and a model group (n = 6 each). A T2DM rat model was established, and the mRNA and protein expression levels of core targets in adipose tissue were measured. Molecular docking and molecular dynamics simulations were performed to assess the binding ability of TCM active components to core targets.
    Results A total of 460 and 796 obesity-related differentially expressed genes were identified in the GSE151839 and GSE162653 datasets, respectively, and 109 shared targets were obtained by intersection with T2DM-related targets. According to PPI network analysis, PTPRC, MMP9, ITGB2, CD86, CCR5, and CCR2 were identified as the core targets. GO and KEGG analysis showed that these targets are mainly enriched in biological processes such as inflammatory response, immune regulation, and cell adhesion. Animal experiments confirmed that the mRNA and protein expression of core targets, including PTPRC, ITGAX, MMP9, ITGB2, CCR2, and CXCL1, were significantly upregulated in the adipose tissue of T2DM rats (P < 0.05). Molecular docking and molecular dynamics simulations revealed that berberine and puerarin had good binding ability with PTPRC, MMP9, and ITGB2.
    Conclusion This study reveals the shared molecular mechanisms between obesity and T2DM and shows that core targets, such as PTPRC and MMP9, may promote disease progression by regulating the inflammation-immune network. These findings provide a theoretical basis for the development of targeted therapeutic strategies based on TCM active ingredients.

     

/

返回文章
返回